Company News: Page (1) of 1 - 02/05/13 Email this story to a friend. email article Print this page (Article printing at page facebook

Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences

(February 05, 2013)

CAMBRIDGE, Mass., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc., (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the 15th Annual BIO CEO & Investor Conference on February 12, 2013 at 3:00 p.m. ET at the Waldorf Astoria, New York City and at the Leerink Swann 2013 Global Healthcare Conference on February 13, 2013 at 8:00 a.m. ET at the Waldorf Astoria, New York City.

The live and archived webcasts of the company presentations can be accessed under "Events and Presentations" in the Idenix Investor Center at Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conferences.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to

CONTACT: Idenix Pharmaceuticals Contacts:
Kelly Barry (617) 995-9033 (media)
Teri Dahlman (617) 995-9807 (investors)

Page: 1

Related Keywords: PHARMACEUTICALS, WEBCASTPro AV, Management, Presentors, Business Issues, Internet Media, Presentation, Corporate/Company, Events, webcast, Inc., healthcare, Surgery, Medication,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved